Title : Potential plasma biomarkers: miRNA-29c, miRNA-21, and miRNA-155 in clinical progression of Hepatocellular Carcinoma patients - Ratnasari_2022_PLoS.One_17_e0263298 |
Author(s) : Ratnasari N , Lestari P , Renovaldi D , Raditya Ningsih J , Qoriansas N , Wardana T , Hakim S , Signa Aini Gumilas N , Indrarti F , Triwikatmani C , Bayupurnama P , Setyo Heriyanto D , Astuti I , Mubarika Harjana S |
Ref : PLoS ONE , 17 :e0263298 , 2022 |
Abstract : Ratnasari_2022_PLoS.One_17_e0263298 |
ESTHER : Ratnasari_2022_PLoS.One_17_e0263298 |
PubMedSearch : Ratnasari_2022_PLoS.One_17_e0263298 |
PubMedID: 35157721 |
Ratnasari N, Lestari P, Renovaldi D, Raditya Ningsih J, Qoriansas N, Wardana T, Hakim S, Signa Aini Gumilas N, Indrarti F, Triwikatmani C, Bayupurnama P, Setyo Heriyanto D, Astuti I, Mubarika Harjana S (2022)
Potential plasma biomarkers: miRNA-29c, miRNA-21, and miRNA-155 in clinical progression of Hepatocellular Carcinoma patients
PLoS ONE
17 :e0263298
Ratnasari N, Lestari P, Renovaldi D, Raditya Ningsih J, Qoriansas N, Wardana T, Hakim S, Signa Aini Gumilas N, Indrarti F, Triwikatmani C, Bayupurnama P, Setyo Heriyanto D, Astuti I, Mubarika Harjana S (2022)
PLoS ONE
17 :e0263298